EAG预激化疗治疗老年急性髓系白血病30例(2)
[参考文献]
[1] 张之南，沈悌.血液病诊断及疗效标准[M].第3版.北京：科学出版社，2007：106-113.
[2] Stone RM.The difficult problem of acute myeloid leukemia in the older adult[J].CA Cancer J Clin，2002，52(6)：363-371.
[3] Yamada K，Furusawa S，Saito K，el a1.Concurrent use of granulocyte colony-stimulating factor with low-dose cytosine arabinoside and aclacubicin for previously treated acute myelogenous leukemia：a pilot study[J].Leukemia，1999，9(1)：10-14.
[4] 王剑利，何爱丽，张王刚，等.HAG预激化疗作为诱导缓解方案治疗老年人急性髓系白血病和骨髓增生异常综合征的临床观察[J].白血病·淋巴瘤，2011，20(3)：151-153.
[5] 吴小津，吴德沛，孙爱宁，等.预激方案诱导治疗老年性急性髓系白血病的疗效观察[J].中华内科杂志，2004，43(12)：936-937.
[6] Saito K，Nakamura Y，Aoyagi M，et al.Low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor(CAG regimen) for previously treated patients with relapsed or primary resistant acute myelogenous leukemia(AML) and refractory anemia with excess blasts in transformation[J].Int J Hematol，2000，7(3)：238-244.
[7] Nakamura Y，Arai Y，Gunji H，et a1.WT1 gene expression in patients with acute myefogenous leukemia or high risk myelodysplastic syndrome successfully treated with CAG regimen[J].Rinsho Ketsueki，2002，43(10)：960-962.
(收稿日期：2011-12-14), 百拇医药(孟昭升 吕振慧)
[1] 张之南，沈悌.血液病诊断及疗效标准[M].第3版.北京：科学出版社，2007：106-113.
[2] Stone RM.The difficult problem of acute myeloid leukemia in the older adult[J].CA Cancer J Clin，2002，52(6)：363-371.
[3] Yamada K，Furusawa S，Saito K，el a1.Concurrent use of granulocyte colony-stimulating factor with low-dose cytosine arabinoside and aclacubicin for previously treated acute myelogenous leukemia：a pilot study[J].Leukemia，1999，9(1)：10-14.
[4] 王剑利，何爱丽，张王刚，等.HAG预激化疗作为诱导缓解方案治疗老年人急性髓系白血病和骨髓增生异常综合征的临床观察[J].白血病·淋巴瘤，2011，20(3)：151-153.
[5] 吴小津，吴德沛，孙爱宁，等.预激方案诱导治疗老年性急性髓系白血病的疗效观察[J].中华内科杂志，2004，43(12)：936-937.
[6] Saito K，Nakamura Y，Aoyagi M，et al.Low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor(CAG regimen) for previously treated patients with relapsed or primary resistant acute myelogenous leukemia(AML) and refractory anemia with excess blasts in transformation[J].Int J Hematol，2000，7(3)：238-244.
[7] Nakamura Y，Arai Y，Gunji H，et a1.WT1 gene expression in patients with acute myefogenous leukemia or high risk myelodysplastic syndrome successfully treated with CAG regimen[J].Rinsho Ketsueki，2002，43(10)：960-962.
(收稿日期：2011-12-14), 百拇医药(孟昭升 吕振慧)